Lumos Pharma is a clinical-stage immuno-oncology company develops immunotherapeutic products for the treatment of patients with cancer. The company's small-molecule product candidates in clinical development target the indoleamine-2, 3-dioxygenase (IDO) pathway, which is a pathway for cancer immune escape. These product candidates, indoximod and NLG802 (a prodrug of indoximod), are IDO pathway inhibitors with mechanisms of action that center around breaking the immune system's tolerance to cancer. The company's small molecule product candidate, NLG207, which is a nanoparticle-drug conjugate, consisting of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase 1 inhibitor.
Peoples Financial Services is a bank holding company. Through its subsidiary, the company provides a range of financial services. The company provides a range of retail and commercial lending products to consumers and small- and medium-sized businesses in its market areas. The company's retail lending products include the following types of loans, among others: residential real estate; automobiles; manufactured housing; personal and home equity. The company's commercial lending products include the following types of loans, among others: commercial real estate; working capital; equipment and other commercial needs; construction; Small Business Administration; and agricultural and mineral rights.
Phibro Animal Health is an animal health and mineral nutrition company. The company develops, manufactures and markets products for a range of food animals including poultry, swine, beef and dairy cattle and aquaculture. The company's products include animal health products such as antibacterials, anticoccidials, nutritional products and vaccines. The company's Animal Health segment also includes antibacterials and other processing aids in the ethanol fermentation industry. The company's mineral nutrition products fortify the animal's diet and help maintain optimal health. The company also manufactures and markets ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.